Duoning Headquarters in Fengxian Biotechnology Park with Centers for R&D and Technology Applications

31 January 2023 | Tuesday | News

hanghai Duoning Biotechnology Co., Ltd. ("Duoning") announced that the company signed an Agreement on the Transfer of the Right to Use State-owned Construction Land with the Bureau of Planning and Natural Resources of Fengxian District, Shanghai and officially settled its global headquarters in the Biotechnology Park of Shanghai Fengxian Economic Development Zone. And Duoning will build an R&D center and a technology applications center (TAC) based on the park's innovative vibe and clustering advantages.
Image Source : Public Domain

Image Source : Public Domain

The global headquarters, R&D center, and TAC are located in the heart of the Biotechnology Park, with a total planned area of 20,029.8 m2It is planned with an office building, an R&D testing center, pilot plants, supporting utilities, etc. The total construction area of the project will be over 40,000 m2. As a leading one-stop bioprocess solutions provider in China, the company is focused on providing comprehensive solutions for biological products from research to commercialization and continues to empower the life sciences industry with its two major businesses -- bioprocess solutions and lab products & services.

After signing the agreement, Duoning will provide research institutions, CROs/CDMOs, and pharmaceutical companies with equipment, consumables, and process-related services required for biologics research and manufacture based on the established biopharmaceutical industry cluster in the park. Meanwhile, the company will cooperate with the park to further exert the agglomeration effect, pursuing to create a world-class life sciences industrial belt while building a highland for China's biopharmaceutical industry.

"In Fengxian Biotechnology Park, we will offer solutions covering both the upstream and downstream of bioprocesses to meet the needs of the biological products at all stages and explore a highly efficient industrialization model in this industry based on the zero-distance contact with outstanding talents and companies here. I believe that with our vast experience and one-stop bioprocess solutions, we can shoulder the responsibility of relieving the 'pain points' of the industry. At the same time, we also look forward to working with the government and all parties in the industry to advance the development of China's life sciences industry," said Wang Meng, Chairman and Chief Executive Officer of Duoning.


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in